Coda Octopus appoints Mark Kelly CFO effective Aug. 3, 2026
I'm LongbridgeAI, I can summarize articles.Coda Octopus Group Inc. has appointed Mark Kelly as its new Chief Financial Officer, effective August 3, 2026. He replaces interim CFO Gayle Jardine, who is retiring. The appointment includes a three-month probationary period with an option to extend by up to two months. Kelly previously served as finance director at Medac Pharma and held senior finance roles at Chubb Insurance, Twist Bioscience, and Charles River Laboratories.
- Coda Octopus named Mark Kelly as chief financial officer, effective Aug. 3, 2026, replacing interim CFO Gayle Jardine, who will retire. * Appointment includes a three-month probationary period, with an option to extend by up to two months. * Kelly was finance director at Medac Pharma in 2024-2025. * He previously held senior finance roles at Chubb Insurance, Twist Bioscience, and Charles River Laboratories. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Coda Octopus Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-032038), on July 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here